Report of Foreign Issuer (6-k)

Date : 02/13/2017 @ 8:59AM
Source : Edgar (US Regulatory)
Stock : Gw Pharmaceuticals Plc. (PC) (GWPRF)
Quote : 10.72  -0.23 (-2.10%) @ 3:59PM

Report of Foreign Issuer (6-k)

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of February, 2017

 

Commission File Number: 001-35892

 

GW PHARMACEUTICALS PLC

(Translation of registrant’s name into English)

 

Sovereign House

Vision Park

Histon

Cambridge CB24 9BZ

United Kingdom

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F    x        Form 40-F    ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes    ¨         No    ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes    ¨         No    ¨

 

 

 

 

 

Annual Meeting of Shareholders

 

GW Pharmaceuticals plc (the “Company”) has announced that its annual meeting of shareholders will be held on March 14, 2017 (the “Annual Meeting”). In that regard, attached hereto as Exhibits 99.1 is a copy of the shareholder circular distributed to shareholders on February 13, 2017 in connection with the Annual Meeting.

 

The Company’s UK Annual Report (the “UK Annual Report”), which contains the Company’s Directors’ Remuneration Report for the year ended September 30, 2016, is being mailed to the Company’s shareholders and also posted on the investor relations section of the Company’s website, www.gwpharm.com. Shareholders may also go to the Investor Relations page of the Company’s website for a copy of the Annual Report on Form 20-F for the year ended September 30, 2016, as well as copies of the Proxy Statement and form of Proxy Card for the Annual Meeting. Please note that the form of Proxy Card on the website is for information purposes only and cannot be used to vote.

 

The information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly set forth by specific reference in such a filing.

 

Exhibits    
99.1   Shareholder Circular

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GW Pharmaceuticals plc
     
  By: /s/ Adam George
  Name: Adam George
  Title: Chief Financial Officer
     
Date: February 13, 2017    

 

 

 

 

Gw Pharmaceuticals Plc. (PC) (USOTC:GWPRF)
Historical Stock Chart

1 Year : From Feb 2016 to Feb 2017

Click Here for more Gw Pharmaceuticals Plc. (PC) Charts.

Gw Pharmaceuticals Plc. (PC) (USOTC:GWPRF)
Intraday Stock Chart

Today : Sunday 19 February 2017

Click Here for more Gw Pharmaceuticals Plc. (PC) Charts.



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.